Project Details
Description
A phase 1, open-label dose-escalation study of SEA-CD40 in adult patients with advanced malignancies
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/17 → 2/28/21 |
Funding
- SEAGEN INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.